BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 20 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $157,123 | +23.5% | 122,752 | +172.0% | 0.00% | – |
| Q1 2024 | $127,250 | -51.0% | 45,124 | -48.7% | 0.00% | – |
| Q4 2023 | $259,455 | -30.4% | 87,951 | -40.3% | 0.00% | – |
| Q3 2023 | $372,879 | -29.7% | 147,383 | +85.2% | 0.00% | – |
| Q2 2023 | $530,136 | +28310.3% | 79,600 | -20.4% | 0.00% | -100.0% |
| Q1 2023 | $1,866 | -99.9% | 100,000 | -47.0% | 0.00% | -50.0% |
| Q2 2022 | $2,489,000 | +514.6% | 188,548 | +872.6% | 0.00% | – |
| Q1 2022 | $405,000 | +3.6% | 19,385 | +0.7% | 0.00% | – |
| Q4 2021 | $391,000 | -37.9% | 19,250 | +31.9% | 0.00% | – |
| Q1 2021 | $630,000 | -77.7% | 14,597 | -76.1% | 0.00% | -100.0% |
| Q4 2020 | $2,825,000 | -21.6% | 61,145 | -26.4% | 0.00% | -50.0% |
| Q3 2020 | $3,604,000 | +105.0% | 83,120 | +150.7% | 0.00% | +100.0% |
| Q2 2020 | $1,758,000 | +1284.3% | 33,161 | +157.7% | 0.00% | – |
| Q1 2019 | $127,000 | -69.8% | 12,869 | -71.9% | 0.00% | -100.0% |
| Q2 2018 | $421,000 | +33.2% | 45,796 | +48.3% | 0.00% | – |
| Q1 2018 | $316,000 | – | 30,889 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 430,000 | $19,866,000 | 1.70% |
| APIS CAPITAL ADVISORS, LLC | 20,000 | $924,000 | 0.89% |
| Avidity Partners Management LP | 547,000 | $25,271,000 | 0.82% |
| Knoll Capital Management, LLC | 20,000 | $924,000 | 0.63% |
| Artemis Investment Management LLP | 1,013,448 | $46,839,000 | 0.49% |
| AlphaCentric Advisors LLC | 25,000 | $1,155,000 | 0.48% |
| First Light Asset Management, LLC | 94,202 | $4,352,000 | 0.32% |
| Ikarian Capital, LLC | 150,000 | $6,930,000 | 0.31% |
| Longitude (Cayman) Ltd. | 8,000 | $370,000 | 0.18% |
| AllSquare Wealth Management LLC | 5,490 | $254,000 | 0.17% |